Literature DB >> 9292250

Direct measurement of free radicals in ischemic/reperfused diabetic rat retina.

M E Szabo1, M T Droy-Lefaix, M Doly.   

Abstract

Electron paramagnetic resonance (EPR) spectroscopy was used to directly measure free radical generation in ischemic/reperfused diabetic rat retina. Tissue was frozen at 77 degrees K after 90 min ischemia, and 90 min ischemia followed by 1 min, 3 min, 5 min, and 24 hours reperfusion, respectively. After 90 min of ischemia followed by 1 min, 3 min, 5 min, and 24 hours of reperfusion (n = 10 in each group), free radical signal intensity was increased from its diabetic nonischemic control value of 12 +/- 3 arbitrary units to 58 +/- 6 (P < 0.05), 62 +/- 7 (P < 0.05), 32 +/- 5 (P < 0.05), and 14 +/- 4 arbitrary units, respectively. The peak intensity of free radical production was observed after 90 min ischemia followed by 3 min of reperfusion; therefore, this time point was selected to study the retinal free radical production in superoxide dismutase (conjugated with polyethylene glycol, PEG-SOD) and EGb 761 (Ginkgo biloba extract)-treated groups. With 7,500, 15,000, and 30,000 U/liter of SOD, and 25, 50, and 100 mg/kg of EGb 761, a dose-dependent reduction in oxygen free radical production was detected, respectively, which may be responsible for the attenuation of abnormal postischemic function in ischemic and reperfused diabetic retina.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9292250

Source DB:  PubMed          Journal:  Clin Neurosci        ISSN: 1065-6766


  11 in total

1.  [Neurodegeneration and neuroprotection].

Authors:  K-G Schmidt
Journal:  Ophthalmologe       Date:  2004-11       Impact factor: 1.059

2.  Protective effects of various antioxidants during ischemia-reperfusion in the rat retina.

Authors:  Nihat Dilsiz; Ayse Sahaboglu; M Zulfu Yildiz; Andreas Reichenbach
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-05       Impact factor: 3.117

Review 3.  Pharmacological neuroprotection for glaucoma.

Authors:  Glyn Chidlow; John P M Wood; Robert J Casson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  Delivery of antioxidant enzyme genes to protect against ischemia/reperfusion-induced injury to retinal microvasculature.

Authors:  Baihua Chen; Sergio Caballero; Soojung Seo; Maria B Grant; Alfred S Lewin
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-23       Impact factor: 4.799

5.  Protection against human immunodeficiency virus type 1 Tat neurotoxicity by Ginkgo biloba extract EGb 761 involving glial fibrillary acidic protein.

Authors:  Wei Zou; Byung Oh Kim; Betty Y Zhou; Ying Liu; Albee Messing; Johnny J He
Journal:  Am J Pathol       Date:  2007-11-30       Impact factor: 4.307

Review 6.  Ginkgo biloba: an adjuvant therapy for progressive normal and high tension glaucoma.

Authors:  A K Cybulska-Heinrich; M Mozaffarieh; J Flammer
Journal:  Mol Vis       Date:  2012-02-09       Impact factor: 2.367

Review 7.  Diet, Oxidative Stress, and Blood Serum Nutrients in Various Types of Glaucoma: A Systematic Review.

Authors:  Maryla Młynarczyk; Martyna Falkowska; Zuzanna Micun; Iwona Obuchowska; Jan Kochanowicz; Katarzyna Socha; Joanna Konopińska
Journal:  Nutrients       Date:  2022-03-29       Impact factor: 5.717

8.  Hypoxia-ischemia and retinal ganglion cell damage.

Authors:  Charanjit Kaur; Wallace S Foulds; Eng-Ang Ling
Journal:  Clin Ophthalmol       Date:  2008-12

Review 9.  Vitreous mediators in retinal hypoxic diseases.

Authors:  Roberto dell'Omo; Francesco Semeraro; Giulio Bamonte; Francesco Cifariello; Mario R Romano; Ciro Costagliola
Journal:  Mediators Inflamm       Date:  2013-01-10       Impact factor: 4.711

10.  Minocycline modulates microglia polarization in ischemia-reperfusion model of retinal degeneration and induces neuroprotection.

Authors:  Amel Ahmed; Lei-Lei Wang; Safaa Abdelmaksoud; Amal Aboelgheit; Safaa Saeed; Chun-Li Zhang
Journal:  Sci Rep       Date:  2017-10-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.